Authors
Latest:
Inherited retinal diseases meet their therapeutic matchThe retina is a key proving ground for long-held theories of genetics.
Latest:
Envision Summit 2025: PULSAR phase 3 trial 96-week post-hoc analysisAt the Envision Summit 2025 in San Juan, Puerto Rico, Deepak Sambhara, MD, gave insight into the 96-week post hoc fluid outcomes analysis of patients who participated in the phase 3 clinical trial PULSAR.
Latest:
The evolving role of vitreosurgical simulators in surgical trainingNeed to eliminate errors results in optimization of training of novice surgeons.
Latest:
Considerations for the Future of Biosimilars in the Treatment of Retinal DisordersCarl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Latest:
Weighing treatments for chronic postop cystoid macular edemaPrompt and adequate action is a key to facilitating the best recovery in patients.
Latest:
Topcon Healthcare selects Daniela Ferrara, MD, as new CMOTopcon Healthcare appoints Daniela Ferrara, MD, PhD, as Chief Medical Officer to enhance AI-driven ocular imaging and advance digital healthcare solutions.
Latest:
Increasing your practice’s reach, relevance, and revenue with clinical trialsWorking as an investigator can prove to be a positive experience for physicians
Latest:
Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLsKamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.
Latest:
EnVision Summit 2025: Complications in glaucoma surgeryAt the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into complications they have seen while performing glaucoma surgery.
Latest:
The eyes offer conjunctival clue to COVID-19A patient's vision loss leads to another diagnosis
Latest:
From waste to wonder: Transformational advances in scleral allograft technologyUnlocking the potential of donor scleral tissue: Innovations and future applications.
Latest:
Patient case 2: DME Patient Treated with Ranibizumab BiosimilarDilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Latest:
EyeCon 2024: Key takeaways for enhanced patient care from Day 1Optometry cochairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, highlight the conference’s focus on collaboration, featuring topics like red flags for patient care, thyroid eye disease, and diabetes management.
Latest:
Driving practice growth: Expand on link between dry eye, aestheticsOne obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
Latest:
Ocular surface health and IOL choicesEnhanced monofocal technology may benefit patients with cataracts and dry eye.
Latest:
Mercy Ships delivers a lifeline for eye health in Africa’s remote communitiesThrough its ophthalmic program, Mercy Ships provides critical eye surgeries and trains local professionals, ensuring sustainable eye care for the future.
Latest:
Protection of eyes during prone positioning must be routinely monitored in ICUTreatment of patients with COVID-19 should include ophthalmic considerations.
Latest:
Unlocking health mysteriesResearchers find a strong link between Alzheimer's disease and retinal thinning
Latest:
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Latest:
Neuropathic dry eye: When serum defeats tearsOphthalmology Times is pleased to announce Melina I. Morkin, MD, and Pedram Hamrah, MD, FACS, of New England Eye Center/Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, as the third-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.
Latest:
Neuropathic dry eye: When serum defeats tearsOphthalmology Times is pleased to announce Melina I. Morkin, MD, and Pedram Hamrah, MD, FACS, of New England Eye Center/Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, as the third-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.
Latest:
Cyclosporine for dry eye associated with anti-PD-1 therapyTopical cyclosporine may be useful for treating dry eyes associated with immunomodulatory agents like nivolumab, which markedly upregulate T cell activation. In caring for patients with ocular side effects associated with cancer treatment, the delivery of proper ophthalmic care is critical.
Latest:
Cyclosporine for dry eye associated with anti-PD-1 therapyTopical cyclosporine may be useful for treating dry eyes associated with immunomodulatory agents like nivolumab, which markedly upregulate T cell activation. In caring for patients with ocular side effects associated with cancer treatment, the delivery of proper ophthalmic care is critical.
